 Englewood Cliffs NJ, Aug. 25, 2021 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO, a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced the filing of three distinct Patent Cooperation Treaty PCT patent applications pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin. 